Yu BY - Search Results

1

[Regulative mechanisms of tubular epithelial to mesenchymal transition and interventional effects of Chinese herbal medicine].

Yin XJ, Sun W, Wan YG, Tu Y, Liu H, Yu BY. Yin XJ, et al. Among authors: yu by. Zhongguo Zhong Yao Za Zhi. 2013 Mar;38(5):648-52. Zhongguo Zhong Yao Za Zhi. 2013. PMID: 23724667 Review. Chinese.

2

[Regulatory mechanism of NF-kappaB signaling pathway on renal tissue inflammation in chronic kidney disease and interventional effect of traditional Chinese medicine].

Liu H, Sun W, Wan YG, Tu Y, Yu BY, Hu H. Liu H, et al. Among authors: yu by. Zhongguo Zhong Yao Za Zhi. 2013 Dec;38(24):4246-51. Zhongguo Zhong Yao Za Zhi. 2013. PMID: 24791524 Review. Chinese.

3

Dahuang Fuzi Decoction ameliorates tubular epithelial apoptosis and renal damage via inhibiting TGF-β1-JNK signaling pathway activation in vivo.

Tu Y, Sun W, Wan YG, Gao K, Liu H, Yu BY, Hu H, Huang YR. Tu Y, et al. Among authors: yu by. J Ethnopharmacol. 2014 Oct 28;156:115-24. doi: 10.1016/j.jep.2014.08.035. Epub 2014 Sep 3. J Ethnopharmacol. 2014. PMID: 25193680

4

Huaiqihuang Granules () reduce proteinuria by enhancing nephrin expression and regulating necrosis factor κB signaling pathway in adriamycin-induced nephropathy.

Liu H, Sun W, Gu LB, Tu Y, Yu BY, Hu H. Liu H, et al. Among authors: yu by. Chin J Integr Med. 2017 Apr;23(4):279-287. doi: 10.1007/s11655-015-2293-0. Epub 2015 Oct 10. Chin J Integr Med. 2017. PMID: 26453563

5

Identification of narciclasine as a novel NRF2 inhibitor.

Ngo HH, Yu BY, Lee JE, Kim H, Keum YS. Ngo HH, et al. Among authors: yu by. Free Radic Res. 2025 Jan 15:1-14. doi: 10.1080/10715762.2025.2451679. Online ahead of print. Free Radic Res. 2025. PMID: 39783823

6

Equity evaluation of intensive care unit admission based on comorbidity in hospitalized patients with COVID-19: a cross-sectional analysis.

Zhu YJ, Wang JY, Wu CN, Yu BY, Liu TT, Liu Y, Zhang LL. Zhu YJ, et al. Among authors: yu by. Front Public Health. 2024 Oct 28;12:1430462. doi: 10.3389/fpubh.2024.1430462. eCollection 2024. Front Public Health. 2024. PMID: 39529718 Free PMC article.

7

[Network Meta-analysis of oral Chinese patent medicine combined with conventional western medicine in treatment of gastro-esophageal reflux disease].

Zhu JX, Yu BY, Li X, Gao R. Zhu JX, et al. Among authors: yu by. Zhongguo Zhong Yao Za Zhi. 2024 Sep;49(17):4786-4800. doi: 10.19540/j.cnki.cjcmm.20240523.501. Zhongguo Zhong Yao Za Zhi. 2024. PMID: 39307813 Chinese.

8

[Value of SOX1 and PAX1 Gene Methylation Detection in Secondary Triage of High-Grade Cervical Lesions].

Guo YP, Yang Q, Wang SR, Li SM, Yu BY, Yang XF. Guo YP, et al. Among authors: yu by. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2024 Jun;46(3):329-333. doi: 10.3881/j.issn.1000-503X.15734. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2024. PMID: 38953256 Free article. Chinese.

9

Discovery of Natural Products Alleviating Renal Fibrosis with a Viscosity-Responsive Molecular Probe.

Zhang K, Sun L, Zhang W, Cao M, Ma X, Yu BY, Xu H, Zheng X, Tian J. Zhang K, et al. Among authors: yu by. Anal Chem. 2024 Apr 23;96(16):6356-6365. doi: 10.1021/acs.analchem.4c00188. Epub 2024 Apr 8. Anal Chem. 2024. PMID: 38588440

10

Understanding the pharmacokinetic journey of Fc-fusion protein, rhIL-7-hyFc using complementary approach of two analytical methods, accelerator mass spectrometry and ELISA.

Kim A, Oh MS, Lee GH, Song S, Byun MS, Choi D, Yu BY, Lee H. Kim A, et al. Among authors: yu by. Antib Ther. 2024 Feb 6;7(2):105-113. doi: 10.1093/abt/tbae004. eCollection 2024 Apr. Antib Ther. 2024. PMID: 38566969 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

355 results

Search Page

Filters